1. Home
  2. IGIC vs YDES Comparison

IGIC vs YDES Comparison

Compare IGIC & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International General Insurance Holdings Ltd.

IGIC

International General Insurance Holdings Ltd.

HOLD

Current Price

$23.82

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$11.36

Market Cap

894.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IGIC
YDES
Founded
2001
2013
Country
Jordan
Taiwan
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
894.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IGIC
YDES
Price
$23.82
$11.36
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$30.33
N/A
AVG Volume (30 Days)
58.8K
57.9K
Earning Date
02-24-2026
09-30-2025
Dividend Yield
4.42%
N/A
EPS Growth
N/A
N/A
EPS
2.81
N/A
Revenue
$525,808,999.00
$510,360.00
Revenue This Year
$17.79
N/A
Revenue Next Year
$3.05
N/A
P/E Ratio
$8.45
N/A
Revenue Growth
N/A
45.76
52 Week Low
$20.82
$5.30
52 Week High
$27.76
$31.00

Technical Indicators

Market Signals
Indicator
IGIC
YDES
Relative Strength Index (RSI) 41.81 N/A
Support Level $23.36 N/A
Resistance Level $24.37 N/A
Average True Range (ATR) 0.63 0.00
MACD -0.17 0.00
Stochastic Oscillator 25.54 0.00

Price Performance

Historical Comparison
IGIC
YDES

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: